What is the treatment for a 13-year-old patient weighing 34 kg with upper respiratory tract infection and typhoid?

Treatment for Upper Respiratory Tract Infection and Typhoid in a 13-Year-Old (34 kg)

Upper Respiratory Tract Infection Management

Most upper respiratory tract infections are viral and do not require antibiotics; supportive care with analgesics and antipyretics is the appropriate treatment unless specific bacterial complications develop. 1

Initial Approach to URI

• Provide supportive care only for uncomplicated URI symptoms including analgesics for pain (acetaminophen or NSAIDs) and antipyretics for fever 2, 3
• Reassure that typical URI symptoms resolve within 7-10 days without antibiotics 3
• Do not prescribe antibiotics for viral URI as they provide no benefit and contribute to resistance 1, 2

When Antibiotics ARE Indicated for URI Complications

Antibiotics should only be considered if bacterial complications develop, specifically: 2, 3

• High fever ≥38.5°C persisting >3 days suggests bacterial superinfection 1, 3
• Symptoms persisting >10 days without improvement suggests acute bacterial rhinosinusitis 2
• Severe symptoms (fever >39°C with purulent nasal discharge for ≥3 consecutive days) 2
• "Double sickening" pattern (initial improvement followed by worsening) 2

If bacterial complication is confirmed, use amoxicillin 80-100 mg/kg/day divided into 3 doses (maximum 3000 mg/day) for this 34 kg patient = approximately 900 mg three times daily. 1, 2

---

Typhoid Fever Treatment

For typhoid fever in this 13-year-old patient, fluoroquinolones (specifically ciprofloxacin or levofloxacin) are the treatment of choice, particularly given the global emergence of multidrug-resistant Salmonella typhi strains. 1, 4, 5

First-Line Antibiotic Selection

Ciprofloxacin is recommended as first-line therapy: 1, 4

• Dose: 15-20 mg/kg/day divided twice daily (for 34 kg = 510-680 mg/day, typically given as 250-350 mg twice daily)
• Duration: 7-10 days 1, 6
• Fluoroquinolones have demonstrated superior efficacy against multidrug-resistant strains and are particularly important in endemic regions 4, 5

Alternative Options

Azithromycin 10-20 mg/kg once daily (maximum 500 mg) for 7 days is an effective alternative: 6

• For this 34 kg patient: 340-680 mg daily (typically 500 mg once daily)
• Demonstrated 88% clinical cure/improvement rate by day 8 and 100% eradication by day 14 6
• Shorter treatment duration (7 days vs 14 days) with once-daily dosing improves compliance 6

Third-generation cephalosporins (ceftriaxone or cefixime) can be used if fluoroquinolones are contraindicated, though resistance patterns vary by region 4, 5

Critical Monitoring Parameters

• Assess clinical response within 48-72 hours of initiating treatment 1
• Monitor for complications including: 7
  • Thrombocytopenia (most common, occurring in 13% of pediatric cases)
  • Intestinal perforation (3%)
  • Gastrointestinal bleeding (3%)
  • Hepatosplenomegaly
  • Neurological complications (delirium, obtundation)
• Severe complications (septic shock, acute respiratory distress syndrome) may require adjunctive high-dose dexamethasone, though pediatric data are limited 8

Important Caveats

• Fluoroquinolone resistance is emerging, particularly in strains from India and Southeast Asia; clinical response may be poor despite in vitro susceptibility 1, 5
• Relapse occurs in approximately 3% of cases even with appropriate therapy; patients require follow-up 7
• Children aged 5-15 years have higher complication rates than younger children 7
• Do not use chloramphenicol as first-line due to widespread resistance and higher MIC90 levels, though it may be considered if susceptibility is confirmed and other options unavailable 6, 7

Concurrent Management

For this patient with both conditions:

• Treat typhoid fever definitively with fluoroquinolone or azithromycin as outlined above
• Provide supportive care for URI symptoms (antipyretics, analgesics)
• Only add specific URI-directed antibiotics (amoxicillin) if clear bacterial URI complications develop as defined above
• The fluoroquinolone used for typhoid will not adequately cover typical bacterial URI pathogens (Streptococcus pneumoniae, Haemophilus influenzae) if complications arise 1